These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 16384552

  • 1. Interaction of ivermectin with multidrug resistance proteins (MRP1, 2 and 3).
    Lespine A, Dupuy J, Orlowski S, Nagy T, Glavinas H, Krajcsi P, Alvinerie M.
    Chem Biol Interact; 2006 Feb 25; 159(3):169-79. PubMed ID: 16384552
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Efflux of depsipeptide FK228 (FR901228, NSC-630176) is mediated by P-glycoprotein and multidrug resistance-associated protein 1.
    Xiao JJ, Foraker AB, Swaan PW, Liu S, Huang Y, Dai Z, Chen J, Sadée W, Byrd J, Marcucci G, Chan KK.
    J Pharmacol Exp Ther; 2005 Apr 25; 313(1):268-76. PubMed ID: 15634944
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Folate concentration dependent transport activity of the Multidrug Resistance Protein 1 (ABCC1).
    Hooijberg JH, Jansen G, Assaraf YG, Kathmann I, Pieters R, Laan AC, Veerman AJ, Kaspers GJ, Peters GJ.
    Biochem Pharmacol; 2004 Apr 15; 67(8):1541-8. PubMed ID: 15041471
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of P-glycoprotein and multidrug resistance protein 1 by dietary phytochemicals.
    Nabekura T, Yamaki T, Ueno K, Kitagawa S.
    Cancer Chemother Pharmacol; 2008 Oct 15; 62(5):867-73. PubMed ID: 18204840
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Several major antiepileptic drugs are substrates for human P-glycoprotein.
    Luna-Tortós C, Fedrowitz M, Löscher W.
    Neuropharmacology; 2008 Dec 15; 55(8):1364-75. PubMed ID: 18824002
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Gomisin A alters substrate interaction and reverses P-glycoprotein-mediated multidrug resistance in HepG2-DR cells.
    Wan CK, Zhu GY, Shen XL, Chattopadhyay A, Dey S, Fong WF.
    Biochem Pharmacol; 2006 Sep 28; 72(7):824-37. PubMed ID: 16889754
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of pluronic P85 on ATPase activity of drug efflux transporters.
    Batrakova EV, Li S, Li Y, Alakhov VY, Kabanov AV.
    Pharm Res; 2004 Dec 28; 21(12):2226-33. PubMed ID: 15648254
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.